Upon completion of the merger, Assertio will become a wholly owned subsidiary of Zydus Lifesciences and will be delisted from the Nasdaq
Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market
Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities
LV Prasad Eye Institute founder recognized for his pioneering contribution to affordable and accessible eye care; award celebrates two decades of honoring transformative humanitarian leadership.
Marketing leader behind growth of brands such as Cipladine, Maxirich, and Soak Shield takes on expanded responsibilities to drive portfolio growth and consumer engagement.
Industry veteran with over two decades of experience to lead expansion across India, South Asia, Southeast Asia, and other high-growth healthcare markets
New annual observance aims to promote safe sun exposure, screening, and preventive healthcare as nearly 77% of Indians are estimated to be Vitamin D deficient
Production at Vadodara facility strengthens Make in India initiative, enhances access to diagnostic testing, and supports preventive healthcare across the country
The new facility aims to accelerate formulation science and application-led research across pharma, biopharma, nutraceuticals, personal care, and home care segments
Partnership will provide funding, incubation, mentorship, and industry exposure for ventures in healthcare, pharmaceuticals, biotechnology, medical technology, and agriculture
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
